Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Early Pipeline Case Study

- PMLiVE

AstraZeneca’s Imfinzi plus chemotherapy shows promise for advanced biliary tract cancer

Updated results from a phase 3 trial showed the combination treatment reduced the risk of death by 24% versus chemotherapy alone

The Sofa Sessions – The Fifth Page

Page & Page Health

Medscape Education: An ESC to Remember

ESC 2022 is now a wrap! The Medscape team was on site with a booth on the exhibit floor, educational symposia, and a Tapas and Trends event where faculty shared...

Medscape Education

- PMLiVE

Creating strong employee engagement and retaining talent in the new normal

By Marie Little

- PMLiVE

Pfizer/BioNTech BA.4/BA.5 COVID-19 booster receives CHMP recommendation

If an authorisation is granted, doses of the bivalent booster will be available to all 27 EU member states

- PMLiVE

Novartis and BeiGene announce positive phase 3 trial results for hepatocellular carcinoma treatment

Hepatocellular carcinoma accounts for 75-85% of liver cancer diagnoses

- PMLiVE

AstraZeneca and Daiichi Sankyo’s Enhertu shows significant improvements for lung cancer patients

Data showed a confirmed objective response rate of 53.8% in patients with HER2-mutant metastatic non-small cell lung cancer

regeneron headquarters

Regeneron’s fianlimab/Libtayo combination shows positive results in advanced melanoma treatment

The results were shared at the European Society for Medical Oncology Congress 2022

Pharmacogenomics

Pharmacogenomics supports and new era of precision medicine

Advances in medical science are always working towards the same goals; to improve quality of life, and clinical and economic outcomes for patients, caregivers, and health providers alike. But drug...

Page & Page Health

- PMLiVE

Building a brighter future with patient support programmes

By Danny Buckland

- PMLiVE

The benefits of patient support programmes in specific disease areas

By Charlotte Maule

- PMLiVE

AstraZeneca shares positive Tagrisso data in patients with EGFR-mutated lung cancer

Lung cancer is the leading cause of cancer death among both men and women

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links